• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Mendel.ai Raises $2M to Launch AI-Powered Medical Matching Service

by Fred Pennic 07/13/2017 Leave a Comment

Mendel.ai, a San Francisco-based startup has raised $2 million in seed funding co-led by DCM Ventures and Bootstrap Lab to launch a new artificial intelligence engine for doctors. The company has developed a new artificial intelligence engine that enables doctors and patients to more quickly find the best diagnostic and treatment methods available for their patients’ medical conditions. Founded by Dr. Karim Galil, Mendel.ai has developed a sophisticated algorithm that understands the unstructured, natural language content within medical documents and is able to make exhaustive inferences without using pre-made, hard-coded rules – an undertaking that is too impractical for human experts to sustain over extended periods of time. Powered by a patient’s comprehensive medical record, rather than limited keywords, the search returns a fully personalized match and evaluates the patient’s eligibility for each suggested treatment. Mendel.ai has built a team of physicians to train the artificial intelligence with real patient data and work with hospitals and cancer genomics companies to improve and introduce Mendel.ai. Initially focus on connecting oncology and cancer patient populations with available clinical trials, the company has already successfully integrated the platform with the UCLA-affiliated Comprehensive Blood & Cancer Center (CBCC) in Bakersfield, CA. The integration will allow the Center’s doctors to quickly and easily match their patients with available clinical trials in a matter of minutes -- a time and resource intensive process that currently takes days or weeks to complete. The process for uncovering the latest, available treatments can often mean a patient never receives the treatment needed to save their life. “As a physician, I have lost patients and family members to terminal cancer diagnosis, only to learn later about clinical trials that could have saved their life,” says Dr. Karim Galil, founder of Mendel.ai in a statement. “Finding the right clinical trials can determine life or death for many cancer patients, but physicians just can’t humanly stay abreast of the thousands of available clinical trials. After realizing the terrible inefficiencies in recruitment procedures for clinical trials, we set out to fix what can potentially save millions of cancer patients.” I work with a San Francisco-based startup called which today announced it launched a new artificial intelligence engine that helps doctors and patients more quickly find the best diagnostic and treatment methods available for specific medical conditions — starting with cancer.

Mendel.ai, a San Francisco-based startup has raised $2 million in seed funding co-led by DCM Ventures and Bootstrap Lab to launch a new artificial intelligence engine for doctors. The company has developed a new artificial intelligence engine that enables doctors and patients to more quickly find the best diagnostic and treatment methods available for their patients’ medical conditions.

Founded by Dr. Karim Galil, Mendel.ai has developed a sophisticated algorithm that understands the unstructured, natural language content within medical documents and is able to make exhaustive inferences without using pre-made, hard-coded rules – an undertaking that is too impractical for human experts to sustain over extended periods of time.

Powered by a patient’s comprehensive medical record, rather than limited keywords, the search returns a fully personalized match and evaluates the patient’s eligibility for each suggested treatment. Mendel.ai has built a team of physicians to train the artificial intelligence with real patient data and work with hospitals and cancer genomics companies to improve and introduce Mendel.ai.

Initially focus on connecting oncology and cancer patient populations with available clinical trials, the company has already successfully integrated the platform with the UCLA-affiliated Comprehensive Blood & Cancer Center (CBCC) in Bakersfield, CA. The integration will allow the Center’s doctors to quickly and easily match their patients with available clinical trials in a matter of minutes — a time and resource intensive process that currently takes days or weeks to complete. The process for uncovering the latest, available treatments can often mean a patient never receives the treatment needed to save their life.

“As a physician, I have lost patients and family members to terminal cancer diagnosis, only to learn later about clinical trials that could have saved their life,” says Dr. Karim Galil, founder of Mendel.ai in a statement. “Finding the right clinical trials can determine life or death for many cancer patients, but physicians just can’t humanly stay abreast of the thousands of available clinical trials. After realizing the terrible inefficiencies in recruitment procedures for clinical trials, we set out to fix what can potentially save millions of cancer patients.”

 

I work with a San Francisco-based startup called  which today announced it launched a new artificial intelligence engine that helps doctors and patients more quickly find the best diagnostic and treatment methods available for specific medical conditions — starting with cancer.

Tagged With: AI Engine, algorithms, Artificial Intelligence, Artificial Intelligence (AI) Software Platform, Artificial Intelligence Companies, DCM Ventures, Deep Learning, Machine Learning, Mendel.ai, Natural Language Processing (NLP), NLP engine, Patient-Provider Matching

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |